Related Experiment Videos

Characterization studies of human tissue-type plasminogen activator produced by recombinant DNA technology

G A Vehar, M W Spellman, B A Keyt

Cold Spring Harbor Symposia on Quantitative Biology

|January 1, 1986

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Modification of epidermal growth factor-like repeats with O-fucose. Molecular cloning and expression of a novel GDP-fucose protein O-fucosyltransferase.

The Journal of biological chemistry·2001

Effective lysis of model thrombi by a t-PA mutant (A473S) that is resistant to alpha2-antiplasmin.

British journal of haematology·2000

Identification of the mechanism responsible for the increased fibrin specificity of TNK-tissue plasminogen activator relative to tissue plasminogen activator.

The Journal of biological chemistry·2000

The effect of O-fucosylation on the first EGF-like domain from human blood coagulation factor VII.

Biochemistry·1999

Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation.

The Journal of biological chemistry·1998

Homologous up-regulation of KDR/Flk-1 receptor expression by vascular endothelial growth factor in vitro.

The Journal of biological chemistry·1998

See all related articles